BridgeBio Oncology Therapeutics to go public via merger with Helix Acquisition Corp. II SPAC, led by Bihua Chen's Cormorant, ...

Jill Wood had pinned her hopes on a little-known federal program to fund her son’s gene therapy. The initiative, which awards ...

William Pao, former Roche R&D leader and Pfizer CDO, now leads Revelio Therapeutics (formerly Launchpad) as CEO, joins ...

Clinical-stage biotech Mission Therapeutics is closing its preclinical laboratory operations in Cambridge, UK, a spokesperson ...

More than a month after its most recent scheduled meeting was postponed, a panel advising the government on a federal ...

CDC investigating 5 hospitalizations in people 65+ for cardiac/neurologic events after receiving Valneva's Ixchiq chikungunya ...

John Coster, CMS' senior technical advisor for the Medicare drug rebate and negotiation group, told Endpoints News that he's ...

Vertex Pharmaceuticals exits liver disease gene editing program with Verve Therapeutics. Verve continues work on a separate ...

Something changed for Bill Anderson when he turned 50. He was ascending the ranks of Roche’s Genentech, but the Texas native ...

Color Health and OpenAI partnered with UCSF to develop an AI copilot for cancer screenings, publishing architecture details ...

Hansoh exits siRNA deal with Silence Therapeutics, Vir seeks partner for hep B combo, Alopexx plans IPO, Medigene-EpimAb partner on T cell engagers, Belite Bio trial cleared ...

Merck, Granules India, Bavarian Nordic lead manufacturing updates. News includes facility builds, acquisitions, partnerships, and EU's Caribbean investment in pharma manufacturing.